Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,218 total articles
Ugwumba Chidozie, who holds a ten percent stake in Clene Inc. (NASDAQ: CLNN), disposed of 39,162 shares of common stock in three transactions from April 15 to April 17, 2026, generating proceeds of $251,897. After the sales, Chidozie continues to indirectly own 362,729 shares through SymBiosis II, LLC. The share sales occurred as CLNN has returned …
Director Laura Oliphant sold 1,716 shares of Aehr Test Systems common stock on April 16, 2026, for $81.54 per share, generating proceeds of $139,922, according to a Form 4 filing. After the sale Oliphant directly holds 16,716 shares, including unvested restricted stock units. The firm reported a record $41 million production order for package-level…
Malisa Chambliss, StandardAero's Chief Human Resources Officer, sold 764 shares of the company on April 16, 2026, generating about $20,903. The sale followed an options exercise the prior day and occurred while the stock was trading below the transaction price. The aerospace services provider reported record fourth-quarter 2025 results, and recent …
Daniella Ballou-Aares, a director at IBEX Ltd (NASDAQ: IBEX), sold $162,809 worth of common shares across transactions in March and December 2025. The director now holds 10,643 shares. The stock trades at $29.72, down roughly 18% over six months, while InvestingPro flags a P/E of 9.8 and notes management share repurchases. IBEX reported stronger-th…
Apogee Therapeutics CFO Jane Henderson sold 2,000 shares on April 16, 2026, for $90.00 per share, generating $180,000 in proceeds. The transaction was executed through a Rule 10b5-1 trading plan. The stock has climbed roughly 178% over the past year and sits close to its 52-week high. Apogee also completed a $403 million underwritten offering and p…
Gregory Clemens Krekeler, President of Component Repair Services at StandardAero, sold 390 shares of company common stock on April 16, 2026, for $27.36 per share, totaling $10670. The transaction follows a series of equity grants and option exercises on April 15 and comes as the company reports record fourth-quarter 2025 results and receives mixed …
Anthony Brancato, President of Engine Services - Business Aviation at StandardAero, sold 1,107 shares on April 16, 2026, to satisfy tax withholding tied to RSU vesting after exercising options. The transaction and recent corporate developments come as analysts revise forecasts amid solid Q4 2025 results and a planned management succession.
Prebble Lewis, President of Engine Services - Airlines & Fleets at StandardAero, Inc. (EXCHANGE:SARO), sold 1,141 shares on April 16, 2026, for $27.36 per share, totaling $31,217. The transaction followed an acquisition of 4,147 shares on April 15. StandardAero recently disclosed record fourth-quarter 2025 results and has seen varying analyst r…
StandardAero Chief Strategy Officer Alex Trapp sold 475 shares on April 16, 2026, for $27.36 each, a transaction totaling $12,996. The trade occurred while SARO shares traded at $26.76, down 6.7% year-to-date, even though InvestingPro’s Fair Value estimate places the stock at $31.68. Trapp also executed stock-related acquisitions on April 15, 2026,…
StandardAero Chief Operating Officer Kimberly Ernzen sold 2,516 shares on April 16, 2026, for $68,837 to satisfy tax withholding tied to restricted stock unit vesting. The move accompanied option exercises and receipt of additional equity awards, while the company reported record fourth-quarter 2025 results and saw mixed analyst actions on price ta…
Marc Drobny, President of Engine Services - Military, Helicopters & Energy at StandardAero, sold 1,094 shares on April 16, 2026, while initiating and receiving multiple equity awards the prior day. The transactions occur against a backdrop of record fourth-quarter 2025 results and recent analyst updates and leadership changes at the company.
Vernon Rogers, Executive Vice President of Sales & Marketing at Aehr Test Systems (NASDAQ:AEHR), sold 5,000 shares on April 16, 2026, at $86.88 per share for $434,400. The company meanwhile reported a record $41 million production order, robust quarterly bookings and a backlog above $50 million, alongside mixed Q3 2026 financials and updated an…
StandardAero finance chief Daniel Satterfield reported a sale of 2,306 common shares on April 16, 2026, at $27.36 per share for $63,092, one day after acquiring 8,538 shares. The company recently posted record fourth-quarter 2025 results and has drawn varied analyst attention, while investing-platform commentary flags the stock as undervalued.
StandardAero Chief Executive Officer Ford Russell Wayne sold 10,638 shares on April 16, 2026, at $27.36 per share for roughly $291,055 to cover tax withholding tied to vested RSUs. The filing also shows simultaneous exercises and awards that expanded his equity position. The company reported record Q4 2025 revenue and EPS, while analysts adjusted m…
Revolution Medicines' CEO Mark A. Goldsmith sold 120,000 shares on April 15, 2026, realizing $18,010,488 at $150.0874 per share and simultaneously exercised 120,000 options. The transactions leave him with both direct and indirect holdings, while the company completed about $2.1 billion in concurrent equity and convertible note offerings and disclo…
Yvonne Wassenaar, a member of Arista Networks Inc's board, sold 1,395 shares on April 15, 2026, for a total of $213,532 under a pre-established Rule 10b5-1 plan. The sales were executed at prices between $151.0697 and $154.72. After the trades, Wassenaar retains direct ownership of 9,784 shares. The move comes amid a wave of positive analyst commen…
Alistair N Sporck, vice president of the Contactor Business Unit at Aehr Test Systems (NASDAQ:AEHR), sold 2,000 shares on April 16, 2026, generating $163,760. The transaction comes while the stock trades close to a 52-week peak after a 937% year-over-year gain. The company also reported a record $41 million production order from a hyperscale custom…
Lynne Parshall, a director at Ionis Pharmaceuticals (IONS), sold 5,000 shares on April 15, 2026, in two transactions totaling $381,366 under a Rule 10b5-1 plan adopted May 6, 2025. The disposals come as the stock has risen 167% over the past year and ahead of an April 29 earnings report. Multiple analyst actions and a new pricing strategy for Tryng…
Ionis Pharmaceuticals Executive Vice President Kyle Jenne sold 4,902 shares on April 16, 2026 in an automatic tax-withholding transaction tied to recently vested restricted stock units. The sale totaled $368,488 at a weighted average price of $75.171. The move comes amid notable analyst activity and new pricing for Tryngolza, with several firms rei…
Joseph Baroldi, Ionis Pharmaceuticals' Executive Vice President and Chief Business Officer, disposed of 5,619 shares on April 16, 2026, in a transaction recorded on a Form 4. The trade, executed at a weighted average price of $74.56 per share and totaling $418,952, coincided with the vesting and release of 10,837 restricted stock units valued at $0…
Brian Birchler, executive vice president at Ionis Pharmaceuticals, sold 973 shares on April 16, 2026, to satisfy tax withholding tied to vested restricted stock units. The sales totaled about $73,015 at a weighted average price of $75.042. Ionis shares trade at $75.71, up 167% over the past year, while several analysts have updated their ratings an…
Photronics director Lee Kang Jyh sold 10,000 shares on April 15, 2026, for $45.1 each, netting $451,000 and leaving him with 375,850 shares. The trade occurred while PLAB shares traded at $48.38, close to a 52-week peak, after a 174% year-over-year gain. Separately, Photronics reported fiscal Q1 2026 results above expectations, saw a price-target l…
Zachary M. Briers, Snap Inc.'s general counsel, sold 11,437 Class A shares on April 15, 2026, for $6.04 each, netting $69,079. The trade was made under a Rule 10b5-1 plan adopted November 17, 2025. The disclosure coincides with Snap's pre-announced first-quarter 2026 results and a workforce reduction intended to generate significant cost savings.
Snap Inc. Chief Business Officer Mohan Ajit sold 28,058 shares of Class A common stock on April 16, 2026, at a weighted average price of $6.0179, generating $168,850 in proceeds. The filing states the sale was made to meet tax withholding obligations tied to the settlement and release of restricted stock units. The transaction was carried out by Ma…
Elizabeth Bhatt, President and COO of Septerna, Inc. (NASDAQ: SEPN), sold 3,990 shares of common stock on April 15, 2026 for about $97,343 and exercised options for 4,000 shares the same day. The transactions leave Bhatt with 174,209 shares directly owned. Septerna reported a narrower-than-expected fourth-quarter loss and revenue driven by a collab…
